Back to results
US 2014/0350004 A1Published application
Amorphous form of dolutegravir
AssigneeMapi Pharma Ltd.
InventorsEhud Marom, Shai Rubnov
Life of this patent
Estimating the term…
Abstract
The present invention provides an amorphous form of dolutegravir sodium, pharmaceutical compositions comprising same, methods for its preparation and use thereof as an antiretroviral agent.
Claims23
An amorphous form of dolutegravir sodium.
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.